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[Clinical Information]
Patient initials or identiﬁer number:
LHM
Relevant clinical history and physical exam:
72 y/o woman with diabetes mellitus, hyperlipidemia, hypertension and left pons
ischemic stroke, had exertional angina off and on in past 2 months
Physical Examination: decrease right side muscle power, otherwise not remarkable.
Relevant test results prior to catheterization:
T-CHO 215 mg/dL, HDL 40 mg/dL, HbA1C: 5.4%, CRE: 0.8 mg/dL.
Thallium Scan: (1) signiﬁcant stress-induced ischemia mixed with scarred myocar-
dium, post-stress ¼ 44% (2) Regional Wall Motion: hypokinesia at apex. (3) Transient
stress-induced LV dilatation.
Relevant catheterization ﬁndings:
Signiﬁcant proximal LAD stenosis to 90-95% with patent LM.
Insigniﬁcant lesion over LCX and RCA.
[Interventional Management]
Procedural step:
We use 6FAL1 guiding catheter and pass SIONwire to distal LAD. Balloon angioplasty
was done with Sprinter Legend 2 X 15mm in order to fascilitate IVUS study. IVUS
examination with Boston Scientiﬁc Atlantis SR Pro 40 MHz showed vessel size to 3.5-
3.75 mm with attenuated plaques. Further balloon angioplasy was done with Abbott
TREK 3.5 X 15 mm. But acute no-ﬂow developed. We ﬁrst deployed Boston Scientiﬁc
Promus Element 3.5 X 32 mm but were unable to establish adequate coronary ﬂow.
Therefore, we administered IC nitroglycerin and tiroﬁban. TIMI 1-2 ﬂow was achieved
and stent edge dissection was noted. Further balloon angioplasy was done with Abbott
TREK 3.5 X 15 mm over the stent edge. Unfortunately, No-ﬂow developed again. This
time, we use Kaneka Thrombuster 6Fr for thrombosuction and also administered IC
adenosine and additional dose of heparin 2500 U. TIMI 3 ﬂow was achieved and stent
edge dissection remained. To cover the stent edge, another Boston Scientiﬁc Promus
Element 3.5 X 12 was implant which resulted in TIMI 3 ﬂow. To end up the procedure,
we performed ﬁnal IVUS examination. To our surprise, there was thrombus inside the
proximal stent. Immediate after IVUS study, no-ﬂow developed again. We use Kaneka
Thrombuster 6Fr for thrombosuction and aslo administered IC adenosine again. Fol-
lowed angiography showed TIMI 3 ﬂow, but one focal ﬁlling defect was noted inside the
proximal stent. In concerned of acute stent thrombosis, balloon angioplasy was done
with Abbott TREK 3.5 X 15 mm again with ﬁnal TIMI 3 ﬂow was achieved. She was
transfer to ICU and continued heparin and tiroﬁban treatment.JACC Vol 63/12/Suppl S j April 22–25, 2014 j TCTAP Abstracts/CASCase Summary:
The patient received the elective LAD PCI. To my suprise, a total of 4 episodes of no-
ﬂow developed during the procedure with peri-procedure MI. The procedure steps
need to be reconsidered again in order to prevent the complication from happening.E/Vulnerable Plaque Diagnosis and Treatment S211
